Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 13, 2023

BUY
$4.28 - $6.57 $2.05 Million - $3.14 Million
477,903 New
477,903 $2.06 Billion
Q3 2019

Nov 13, 2019

SELL
$12.27 - $15.79 $16.5 Million - $21.2 Million
-1,341,943 Closed
0 $0
Q2 2019

Aug 13, 2019

BUY
$13.37 - $18.85 $1.09 Million - $1.54 Million
81,655 Added 6.48%
1,341,943 $18.9 Million
Q1 2019

May 14, 2019

BUY
$17.59 - $31.05 $18.3 Million - $32.3 Million
1,039,440 Added 470.66%
1,260,288 $23.2 Million
Q4 2018

Feb 13, 2019

SELL
$18.97 - $31.47 $1.97 Million - $3.27 Million
-103,752 Reduced 31.96%
220,848 $5.77 Million
Q3 2018

Nov 13, 2018

SELL
$18.25 - $23.0 $5.03 Million - $6.33 Million
-275,400 Reduced 45.9%
324,600 $7.45 Million
Q2 2018

Aug 14, 2018

SELL
$13.95 - $19.15 $5.36 Million - $7.36 Million
-384,584 Reduced 39.06%
600,000 $11.4 Million
Q1 2018

May 14, 2018

BUY
$14.05 - $20.2 $1.4 Million - $2.01 Million
99,584 Added 11.25%
984,584 $16.6 Million
Q4 2017

Feb 13, 2018

BUY
$12.85 - $18.1 $7.52 Million - $10.6 Million
585,000 Added 195.0%
885,000 $13.5 Million
Q3 2017

Nov 13, 2017

SELL
$15.4 - $18.85 $5.93 Million - $7.26 Million
-385,086 Reduced 56.21%
300,000 $5.37 Million
Q2 2017

Aug 14, 2017

BUY
N/A
685,086
685,086 $11.2 Million

Others Institutions Holding VNDA

About Vanda Pharmaceuticals Inc.


  • Ticker VNDA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 56,561,500
  • Market Cap $249M
  • Description
  • Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under developme...
More about VNDA
Track This Portfolio

Track Stonepine Capital Management, LLC Portfolio

Follow Stonepine Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Stonepine Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Stonepine Capital Management, LLC with notifications on news.